Abstract:Nrf2 is a key transcription factor that regulates redox status by up‐regulating a broad array of antioxidant genes. Previous data from our laboratory demonstrated that enhanced oxidative stress in the RVLM contributed to the sympatho‐excitation in rabbits with chronic heart failure (HF). Accordingly, we hypothesized that overexpression of Nrf2 in the RVLM will suppress sympathetic tone via enhancing antioxidant defense. Thirty C57BL/6 mice were randomized into four groups: Sham‐lentiviral GFP (7); Sham‐lentiviral GFP Nrf2 (7); HF‐lenti GFP (8); and HF‐lenti GFP Nrf2 (8). HF was induced by coronary artery ligation while sham surgery was used as the control. Nrf2 was upregulated selectively in glutamatergic neurons of RVLM by microinjection of Ca2+/calmodulin‐dependent protein kinase‐II (CaMKII) promoter‐driven Nrf2 lentivirus and a corresponding GFP vector was used as the control. We found that (1) Nrf2 protein was significantly downregulated in the RVLM of HF mice, which was restored by Nrf2 gene transfer. (2) The increased urinary NE excretion in HF was attenuated by Nrf2 overexpression (Sham‐GFP: 575.2 ± 265.0, HF‐GFP, 1119.6 ± 270.5, HF‐Nrf2: 812.1 ± 133.0 ng/24hr. *p < 0.05, n = 7–8/group). (3) Radio telemetry experiments (in the conscious state) showed that Nrf2 overexpression enhanced spontaneous baroreflex gain and increased PE induced bradycardia in HF (Decline of HR: Sham‐GFP: −53.7 ± 4.8; HF−GFP: −4.7 ± 5.1; HF‐Nrf2: −25.1 ± 2.3 % of Max. *P < 0.05 HF‐GFP vs Sham‐GFP and HF‐Nrf2 vs HF‐GFP, n = 7–8/group), and attenuated stress‐induced pressor responses in both Sham (surgical‐stress: 101.5 ± 5.9 vs 129.7 ± 7.2 mmHg, restraint‐stress: 118.8 ± 6.8 vs 151.5 ± 8.2 mmHg. *P < 0.05, n = 7/group) and HF mice (surgery‐stress: 111.06 ± 5.87 vs 135.83 ± 7.24 mmHg, restrain‐stress: 102.8 ± 8.2 vs 119.2 ± 6.3 mmHg. *P < 0.05, n = 8/group). No difference in baseline blood pressure and heart rate were observed among these groups. (4) Acute experiments (in the anesthetized state) revealed a decrease in basal renal sympathetic nerve activity (Sham‐GFP: 28.6 ± 5.2, HF‐GFP: 64.7 ± 8.3, HF‐Nrf2: 44.0 ± 6.5 % of Max. *P < 0.05 HF‐GFP vs Sham‐GFP and HF‐Nrf2 vs HF‐GFP, n = 7–8/group) and improvement of baroreflex sensitivity (Maximal Gain: Sham‐GFP: 2.9 ± 0.1, HF‐GFP: 1.1 ± 0.2, HF‐Nrf2: 1.8 ± 0.3 % of mmHg. **p < 0.01 HF‐GFP vs Sham‐GFP; *P < 0.05 HF‐Nrf2 vs HF‐GFP, n = 7–8/group) in HF mice by Nrf2 overexpression. Based on the above data, we conclude that upregulating Nrf2 expression in glutamatergic neurons of the RVLM ameliorates sympathetic regulation in mice with HF and attenuates stress‐induced pressor responses in both sham and HF mice.Support or Funding InformationSupported by NIH grant P01‐HL62222This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

GW26-e1037 Tanshinones IIA Attenuated Oxidative Stress and Restored Balance between Pro- and Anti-inflammatory Cytokines in Hypothalamic Paraventricular Nucleus Contribute to Sympathoexcitation in Chronic High-Salt Intake Induced Hypertension

Macrophage migration inhibitory factor in the paraventricular nucleus plays a major role in the sympathoexcitatory response to salt.

Macrophage Migration Inhibitory Factor in Hypothalamic Paraventricular Nucleus Neurons Decreases Blood Pressure in Spontaneously Hypertensive Rats

High Salt Challenge Augments Expression of Proinflammatory Cytokines and Contributes to Elevated Neuronal Activity in the Hypothalamic Paraventricular Nucleus

Central Hypertonic Nacl Increases Cytokine Expression in the Hypothalamic Paraventricular Nucleus

Macrophage Migration Inhibitory Factor Deficiency Augments Cardiac Dysfunction in Type 1 Diabetic Murine Cardiomyocytes

SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy

PL-010 Chronic Mild Stress Improves Glucose Homeostasis Via Myonectin-Mediated Suppression of Sympathetic Activity in High-Fat Diet-Fed Mice

Intermedin in Paraventricular Nucleus Attenuates Sympathoexcitation and Decreases TLR4-Mediated Sympathetic Activation via Adrenomedullin Receptors in Rats with Obesity-Related Hypertension

Ventromedial Hypothalamus Activation Aggravates Hypertension Myocardial Remodeling Through the Sympathetic Nervous System

Novel mechanism within the paraventricular nucleus reduces both blood pressure and hypothalamic pituitary-adrenal axis responses to acute stress.

Overexpression of macrophage migration inhibitory factor protects against pressure overload-induced cardiac hypertrophy through regulating the miR-29b-3p/HBP1 axis

Targeting Interleukin-1 Beta to Suppress Sympathoexcitation in Hypothalamic Paraventricular Nucleus in Dahl Salt-Sensitive Hypertensive Rats

Blockade of Microglial Activation in Hypothalamic Paraventricular Nucleus Improves High Salt-Induced Hypertension

Intermedin in Paraventricular Nucleus Attenuates Ang II-Induced Sympathoexcitation through the Inhibition of NADPH Oxidase-Dependent ROS Generation in Obese Rats with Hypertension

Synergistic cardiac pathological hypertrophy induced by high-salt diet in IGF-IIRα cardiac-specific transgenic rats

Inhibition of Microbiota-dependent Trimethylamine N-Oxide Production Ameliorates High Salt Diet-Induced Sympathetic Excitation and Hypertension in Rats by Attenuating Central Neuroinflammation and Oxidative Stress

Activation of FMS-like Tyrosine Kinase 3 Protects Against Isoprenaline-Induced Cardiac Hypertrophy by Improving Autophagy and Mitochondrial Dynamics.

Enhanced cardiovascular alteration and Fos expression induced by central salt loading in a conscious rat transgenic for the metallothionein-vasopressin fusion gene.

Overexpression of Nrf2 Targeting Glutamatergic Neurons in the RVLM Ameliorates Sympathetic Regulation in Mice with Chronic Heart Failure

Intermedin Restores Hyperhomocysteinemia-induced Macrophage Polarization and Improves Insulin Resistance in Mice